212 related articles for article (PubMed ID: 7647999)
1. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.
Beisiegel U
Curr Opin Lipidol; 1995 Jun; 6(3):117-22. PubMed ID: 7647999
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
[TBL] [Abstract][Full Text] [Related]
3. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated mechanisms of lipoprotein remnant catabolism.
Chappell DA; Medh JD
Prog Lipid Res; 1998 Dec; 37(6):393-422. PubMed ID: 10209655
[TBL] [Abstract][Full Text] [Related]
5. VLDL receptor mediates the uptake of human chylomicron remnants in vitro.
Niemeier A; Gàfvels M; Heeren J; Meyer N; Angelin B; Beisiegel U
J Lipid Res; 1996 Aug; 37(8):1733-42. PubMed ID: 8864957
[TBL] [Abstract][Full Text] [Related]
6. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins.
Dergunov AD; Rosseneu M
Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390
[TBL] [Abstract][Full Text] [Related]
7. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at beta-VLDL receptor.
Nestel PJ; Billington T; Bazelmans J
Biochim Biophys Acta; 1985 Dec; 837(3):314-24. PubMed ID: 4063383
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP).
Krapp A; Ahle S; Kersting S; Hua Y; Kneser K; Nielsen M; Gliemann J; Beisiegel U
J Lipid Res; 1996 May; 37(5):926-36. PubMed ID: 8725146
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein binding to cultured human hepatoma cells.
Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
[TBL] [Abstract][Full Text] [Related]
11. Hepatic binding of triglyceride-rich lipoproteins in humans.
Florén CH
Scand J Clin Lab Invest; 1985 Oct; 45(6):531-7. PubMed ID: 2999965
[TBL] [Abstract][Full Text] [Related]
12. [Physiology and pathophysiology of the metabolism of lipoproteins].
Sandhofer F
Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
Dergunov AD
Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
[TBL] [Abstract][Full Text] [Related]
14. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
Takahashi S; Sakai J; Fujino T; Hattori H; Zenimaru Y; Suzuki J; Miyamori I; Yamamoto TT
J Atheroscler Thromb; 2004; 11(4):200-8. PubMed ID: 15356379
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
[TBL] [Abstract][Full Text] [Related]
16. The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.
Nakajima K; Tokita Y; Tanaka A; Takahashi S
Clin Chim Acta; 2019 Aug; 495():382-393. PubMed ID: 31078566
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.
Windler E; Havel RJ
J Lipid Res; 1985 May; 26(5):556-65. PubMed ID: 4020294
[TBL] [Abstract][Full Text] [Related]
18. Chylomicron remnants: hepatic receptors and metabolism.
Havel RJ
Curr Opin Lipidol; 1995 Oct; 6(5):312-6. PubMed ID: 8520854
[TBL] [Abstract][Full Text] [Related]
19. Roles of lipoprotein lipase and hepatic triglyceride lipase in the catabolism in vivo of triglyceride-rich lipoproteins.
Reardon MF; Sakai H; Steiner G
Arteriosclerosis; 1982; 2(5):396-402. PubMed ID: 7126037
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
